[西班牙2023年终身接种疫苗的最新成本]
Sonia Fernández Conde1, Daniel Cifo Arcos2, Laura Sánchez-Cambronero Cejudo1
1Área de Programas de Vacunación; Ministerio de Sanidad. Madrid. España.
Revista espanola de salud publica
|January 11, 2024
概括
到2023年,西班牙的疫苗接种终身成本增加了125%,为女性1541.56欧元,男性1498.18欧元. 尽管成本上升,免疫仍然是一个具有成本效益的公共卫生干预措施.
科学领域:
- 公共卫生 公共卫生
- 卫生经济学 卫生经济学
- 免疫接种计划 免疫接种计划
背景情况:
- 国家卫生系统的领土间理事会 (CISNS) 在2023年更新了其终身疫苗接种计划,其中有四项修改.
- 估计疫苗的终身成本对于资源分配和卫生政策决策至关重要.
研究的目的:
- 估计西班牙2023年健康个体和患有特定风险状况的人群接种疫苗的终身成本.
- 将这些成本与2019年之前的估计进行比较.
主要方法:
- 进行了一项描述性研究,以计算2023年终身疫苗接种计划和风险群体疫苗接种计划中包含的疫苗的管理成本.
- 对健康个体和特定风险条件的成本进行了分析.
主要成果:
- 2023年,一个健康人一生的免疫接种成本为女性1,541.56欧元,男性1,498.18欧元,比2019年增加125%.
- 最高的成本与阿斯普利尼亚,补充缺乏症和原发性免疫缺陷有关,平均分别为3,159.82欧元和2,566欧元.
- 整个健康人口接种疫苗的年度成本约为5.65亿欧元;2023年新生儿队列成本估计为5亿欧元.
结论:
- 尽管在2023年成本大幅增加,但终身免疫仍然是一个非常具有成本效益的干预措施.
- 通过疫苗接种预防疾病的经济效益超过了不断上升的成本,突出了它的价值.
相关概念视频
Vaccinations
44.5K
Overview
44.5K
Cancer Vaccines
368
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
368
Preventive Healthcare Services
1.0K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.0K
Prevalence and Incidence
534
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
534
Development of Immunocompetence
309
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
309
Population Growth
25.3K
Population size is dynamic, increasing with birth rates and immigration, and decreasing with death rates and emigration. In ideal conditions with unlimited resources, populations can increase exponentially, which plots as a J-shaped growth rate curve of population size against time. This type of curve is characteristic of newly-introduced invasive species, or populations that have suffered catastrophic declines and are rebounding.
25.3K


